Aurinia Pharmaceuticals Inc (AUPH)

19.15 +0.48  +2.57% NASDAQ Dec 6, 16:00 19.15 0.00  0.00% After-Hours: 20:00 USD

Aurinia Pharmaceuticals SG&A Expense (Quarterly):

44.13M for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

SG&A Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Historical SG&A Expense (Quarterly) Data

View and export this data going back to 1999. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 44.13M
June 30, 2021 43.79M
March 31, 2021 39.28M
Dec. 31, 2020 38.78M
Sept. 30, 2020 30.70M
June 30, 2020 15.45M
March 31, 2020 11.05M
Dec. 31, 2019 7.43M
Sept. 30, 2019 6.061M
June 30, 2019 4.946M
March 31, 2019 3.901M
Dec. 31, 2018 3.518M
Sept. 30, 2018 2.923M
June 30, 2018 3.462M
March 31, 2018 3.791M
Dec. 31, 2017 3.118M
Sept. 30, 2017 2.65M
June 30, 2017 2.901M
March 31, 2017 3.427M
Dec. 31, 2016 2.227M
Sept. 30, 2016 1.716M
June 30, 2016 1.835M
March 31, 2016 1.192M
Dec. 31, 2015 1.564M
Sept. 30, 2015 1.38M
   
June 30, 2015 1.414M
March 31, 2015 1.905M
Dec. 31, 2014 1.399M
Sept. 30, 2014 1.405M
June 30, 2014 1.713M
March 31, 2014 2.373M
Dec. 31, 2013 0.821M
Sept. 30, 2013 0.492M
June 30, 2013 0.491M
March 31, 2013 0.494M
Dec. 31, 2012 0.9029M
Sept. 30, 2012 0.9896M
June 30, 2012 0.9743M
March 31, 2012 0.9883M
Dec. 31, 2011 0.7717M
Sept. 30, 2011 0.6572M
June 30, 2011 0.6773M
March 31, 2011 0.7295M
Dec. 31, 2010 1.150M
Sept. 30, 2010 0.755M
June 30, 2010 0.6423M
March 31, 2010 0.7161M
Dec. 31, 2009 0.732M
Sept. 30, 2009 0.6315M
June 30, 2009 1.133M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Benchmarks

Bristol-Myers Squibb Co 1.788B
Edesa Biotech Inc 1.608M
Liminal Biosciences Inc 7.479M

SG&A Expense (Quarterly) Range, Past 5 Years

Minimum 2.227M Dec 2016
Maximum 44.13M Sep 2021
Average 13.68M

News

Top Midday Decliners
MT Newswires 11/22 13:57 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.